Redesigned Apple Watches not subject to import ban, US Customs says
The Hindu
The import ban, issued by the US International Trade Commission (ITC), applies to Apple’s current Series 9 and Ultra 2 watches and initially went into effect on December 26.
A US law enforcement agency has determined that Apple can use a redesign to bypass an import ban on newer Apple Watch models stemming from its patent infringement dispute with Masimo, the medical-monitoring technology company said in a court filing on Monday.
The import ban, issued by the US International Trade Commission (ITC), applies to Apple's current Series 9 and Ultra 2 watches and initially went into effect on Dec. 26. Apple convinced the U.S. Court of Appeals for the Federal Circuit to pause the ban the next day, and has since resumed selling the watches as it contests the import ruling.
Apple had said that a proposed redesign would allow it to circumvent findings that the watches infringe Masimo's blood-oxygen reading pulse oximetry patents. Apple has not publicly described the redesign, which could involve an update to the watches' software.
According to Masimo's filing on Monday with the Federal Circuit, Apple told the U.S. Customs and Border Protection agency that its redesigned watches "definitively do not contain pulse oximetry functionality." Apple's filings with U.S. Customs and the agency's decision, issued Friday, have not been released publicly.
(For top technology news of the day, subscribe to our tech newsletter Today’s Cache)
Masimo may ask the ITC to overrule the customs agency's decision. Representatives for Apple and Masimo did not immediately respond to requests for comment on Monday.
Irvine, California-based Masimo has accused Apple of hiring away its employees and stealing its pulse oximetry technology to use in Apple Watches after discussing a potential collaboration.
The girl, who was admitted to Aster CMI Hospital with alarming breathlessness and significant pallor, was diagnosed with Wegener’s Granulomatosis (now known as Granulomatosis with Polyangiitis or GPA), a rare autoimmune condition that causes spontaneous bleeding in the lungs, leading to acute respiratory failure.
ACB files case against IPS officer N. Sanjay in Andhra Pradesh. The official is accused of manipulating the tender processes for awarding contract for development and maintenance of AGNI-NOC portal, and conducting awareness meetings for SC/STs. It is alleged that the total value of properties stolen, or involved in the case is estimated at ₹1,75,86,600.